Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the European Medicines Agency (EMA) on 20 June 2025 ...

Final curative treatment: ... Causes of Hyperandrogenism, Other Than Polycystic Ovarian Syndrome, Which Merit Consideration, Especially if Irregularity of the Menstrual Cycle Does not Date Back to ...

Treatment and Management ... [4,7,9] Clinical and/or biochemical hyperandrogenism with menstrual infrequency is found commonly in women with Cushing's syndrome. In fact, ...

Final curative treatment: Laparoscopic right adrenalectomy: ... Table 2. Causes of Hyperandrogenism, Other Than Polycystic Ovarian Syndrome, Which Merit Consideration, ...

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2 A phase II trial has recently been ...

The study is intended to focus on diagnostics and treatment of Lyme IACI symptoms and not to improve diagnostics and treatment for acute Lyme disease. As such, the prevention of Lyme disease ...